$CAL

Transcript: Caleres Q2 2026 Earnings Conference Call - Caleres (NYSE:CAL)

Caleres (NYSE:CAL) reported Q2 2026 adjusted earnings above expectations, with $695M in sales, up 5.6% YoY. Brand Portfolio sales rose 23.6%, while Famous Footwear declined 6.3%. The company raised its adjusted EPS guidance for the full year, focusing on international growth and integrating Stuart Weitzman.

Original reporting
Published Sep 10, 2026, 2:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 5:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transcript: Caleres Q2 2026 Earnings Conference Call - Caleres (NYSE:CAL) — source image
Decision brief

The 30-second read

$CALBullishMed
01

Why it matters

Q2 results and segment commentary suggest Brand Portfolio momentum and international outperformance are offsetting Famous Footwear timing and assortment headwinds. The raised lower end of full-year adjusted EPS guidance is the key decision-relevant update.

02

Market read

Traders can reassess CAL’s earnings outlook based on the guidance adjustment and the balance of Brand Portfolio strength versus Famous Footwear weakness.

03

What to watch

International growth is strong, but the excerpt does not quantify margin impact or inventory/clearance dynamics; DTC outlet and clearance pressure could re-emerge and cap upside.

Relevance 7/10Novelty 7/10Timing: during/after Caleres Q2 2026 earnings call (published pre/post transcript)

Background

Caleres frames 2026 as a build-back year focused on restoring earnings power, integrating Stuart Weitzman, and expanding international penetration.

Company-level read

Ticker impact

$CALBullishMedium confidence
Context

Caleres reported Q2 adjusted earnings above expectations, raised the lower end of full-year adjusted EPS guidance, and highlighted Brand Portfolio strength versus Famous Footwear weakness.

Expected impact

Near-term bias toward upside as traders price in improved earnings power, tempered by continued pressure in Famous Footwear.

Evidence & confidence

The article contains multiple company-specific datapoints: Q2 sales and segment performance, international growth rates, and a guidance adjustment. However, it is a transcript and the excerpt does not include the exact EPS/guidance figures beyond directional language, limiting precision.

Market effects

Provides read-through on discretionary footwear demand and the relative resilience of fashion-led brands versus lifestyle athletic assortments.

International growth is emphasized as the company’s largest growth vector, which may influence sentiment toward retailers with global expansion exposure.

Limited direct global macro linkage; primarily company-specific within consumer footwear retail.

Counterpoint

The guidance change is only at the lower end, and Famous Footwear remains pressured, so the market may still discount durability of consolidated earnings power.

Key entities

  • Caleres Incorporated

    Reported Q2 adjusted earnings above expectations, Brand Portfolio growth, international sales acceleration, and raised the lower end of full-year adjusted EPS guidance.

  • Stuart Weitzman

    Integration progress highlighted, with improvement in full-price sell-through and international performance.

  • Famous Footwear

    Sales pressured by a delayed back-to-school season and a shift away from lifestyle athletic products.

Related articles

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 2026 results with net sales up 5.6% YoY to $695.5M, but organic sales excluding Stuart Weitzman declined 0.8%. Brand Portfolio sales grew 8.2% with margin expansion, while Famous Footwear sales fell 6.3%. Adjusted EPS rose to $0.47. The company raised full-year EPS guidance to $1.50-$1.65. Management highlights strategic shift to premium brands and higher-margin channels.

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 net sales of $695.5M, up 5.6%, and adjusted EPS of $0.47, up from $0.35. Its brand portfolio, including Sam Edelman and Stuart Weitzman, saw sales rise 23.6%, while Famous Footwear sales fell 6.3%. The company raised its full-year guidance but cited inventory and tariff uncertainties.

$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

$CALHighAI 8/10

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.

$CALMedAI 8/10

Caleres Q2 Earnings Call Highlights

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.